CureVac NV (CVAC US)

Analysis

Health Care • United States

CureVac N.V. operates as a global clinical-stage biopharmaceutical company. The Company focuses on developing a new class of transformative medicines based on messenger ribonucleic acid that has the potential to improve the lives of people. CureVac serves customers worldwide.

Refresh

Company Presentation • 15 May 2025 19:00

Investor Presentation

Company Presentation • 31 Jan 2024 20:00

Investor Presentation

Company Presentation • 28 Jun 2024 19:00

Investor Presentation

Company Presentation • 10 Apr 2025 19:00

Investor Presentation

Company Presentation • 13 Jan 2025 20:00

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00